Center-Authored Papers

Filters: Author is Thomas, Duncan C  [Clear All Filters]
Journal Article
Capanu M, Concannon P, Haile RW, Bernstein L, Malone KE, Lynch CF, Liang X, Teraoka SN, Diep AT, Thomas DC et al..  2011.  Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling.. Genetic epidemiology. 35(5):389-97. Abstract
Robson ME, Reiner AS, Brooks JD, Concannon PJ, John EM, Mellemkjaer L, Bernstein L, Malone KE, Knight JA, Lynch CF et al..  2017.  Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.. Journal of the National Cancer Institute. 109(10) Abstract
Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P et al..  2010.  Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.. Human mutation. 31(3):E1200-40. Abstract
Cicek MS, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Diergaarde B, Haile RW, Le Marchand L, Krontiris TG, Younghusband BH et al..  2012.  Colorectal Cancer Linkage on Chromosomes 4q21, 8q13, 12q24, and 15q22.. PloS one. 7(5):e38175. Abstract
Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS et al..  2013.  Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report.. European journal of cancer (Oxford, England : 1990). 49(14):2979-2985. Abstract
Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK et al..  2018.  Discovery of common and rare genetic risk variants for colorectal cancer.. Nature genetics. Abstract
Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF et al..  2008.  Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.. International journal of radiation oncology, biology, physics. 72(4):1021-30. Abstract
Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B et al..  2008.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.. Journal of the National Cancer Institute. 100(1):32-40. Abstract
Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang S-C, Fischer CP, Harju JF et al..  2015.  Genome-wide association study of colorectal cancer identifies six new susceptibility loci.. Nature communications. 6:7138. Abstract
Ahsan H, Halpern J, Kibriya MG, Pierce BL, Tong L, Gamazon ER, McGuire V, Felberg A, Shi J, Jasmine F et al..  2014.  A Genome-wide Association Study of Early-onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(4):658-69. Abstract
Salomon MP, Li WLS, Edlund CK, Morrison J, Fortini BK, Win AK, Conti DV, Thomas DC, Duggan D, Buchanan DD et al..  2016.  GWASeq: targeted re-sequencing follow up to GWAS.. BMC genomics. 17(1):176. Abstract
Chung CC, Kanetsky PA, Wang Z, Hildebrandt MAT, Koster R, Skotheim RI, Kratz CP, Turnbull C, Cortessis VK, Bakken AC et al..  2013.  Meta-analysis identifies four new loci associated with testicular germ cell tumor.. Nature genetics. 45(6):680-5. Abstract
Hsu L, Jeon J, Brenner H, Gruber SB, Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du M, Gong J et al..  2015.  A Model to Determine Colorectal Cancer Risk Using Common Genetic Susceptibility Loci.. Gastroenterology. 148(7):1330-9.e14. Abstract
Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al..  2010.  Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(14):2404-10. Abstract
Bernstein JL, Haile RW, Stovall M, Boice JD, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH et al..  2010.  Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.. Journal of the National Cancer Institute. 102(7):475-83. Abstract
Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X et al..  2011.  Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology (WECARE) study.. Breast cancer research : BCR. 13(6):R114. Abstract
Thomas DC, Conti DV, Baurley J, Nijhout F, Reed M, Ulrich CM.  2009.  Use of pathway information in molecular epidemiology.. Human genomics. 4(1):21-42. Abstract
Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S et al..  2012.  Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.. Human mutation. 33(1):158-164. Abstract
Concannon P, Haile RW, Børresen-Dale A-L, Rosenstein BS, Gatti RA, Teraoka SN, Diep AT, Jansen L, Atencio DP, Langholz B et al..  2008.  Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.. Cancer research. 68(16):6486-91. Abstract
Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF et al..  2008.  Variation of breast cancer risk among BRCA1/2 carriers.. JAMA : the journal of the American Medical Association. 299(2):194-201. Abstract